Cargando…
Treatment of hemolytic uremic syndrome related to Bordetella pertussis infection —is plasma exchange or eculizumab use necessary?
BACKGROUND: Bordetella pertussis infection is a known trigger of atypical hemolytic uremic syndrome (HUS). For patients suspected of having atypical HUS, prompt plasma exchange/infusion (PE/PI) or eculizumab (ECZ) treatment is recommended. CASE PRESENTATION: We report a 1-month-old female infant who...
Autores principales: | Saida, Ken, Ogura, Masao, Kano, Yuji, Ishimori, Shingo, Yoshikawa, Takahisa, Nagata, Hiroko, Sato, Mai, Kamei, Koichi, Ishikura, Kenji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297948/ https://www.ncbi.nlm.nih.gov/pubmed/30558570 http://dx.doi.org/10.1186/s12882-018-1168-y |
Ejemplares similares
-
Influenza virus vaccination in children with nephrotic syndrome: insignificant risk of relapse
por: Ishimori, Shingo, et al.
Publicado: (2020) -
Pharmacokinetics and Pharmacodynamics Estimation of Eculizumab in a 2-Year-Old Girl With Atypical Hemolytic Uremic Syndrome: A Case Report With 4-Year Follow-Up
por: Saida, Ken, et al.
Publicado: (2019) -
Critical appraisal of eculizumab for atypical hemolytic uremic syndrome
por: Palma, Lilian M Pereira, et al.
Publicado: (2016) -
Atypical hemolytic uremic syndrome and eculizumab therapy in children
por: Kim, Seong Heon, et al.
Publicado: (2018) -
Treatment of Atypical Hemolytic-Uremic Syndrome in the Era of Eculizumab
por: Ebrahem, Rawaa, et al.
Publicado: (2017)